	销售和管理费用		日
Akebia Therapeutics	USD 23.53M	3.19M	2025-12
Alaunos Therapeutics	USD 585K	84K	2025-09
ALKERMES	USD 187.2M	15.43M	2025-12
Avita Medical	AUD 19.03M	1.95M	2025-12
Dianthus Therapeutics	USD 6.57M	1.62M	2025-12
Eurofins Scientific SE	EUR 0	0	2023-06
Ionis Pharmaceuticals	USD 130M	43.43M	2025-12
IQVIA Holdings	USD 468M	46M	2025-12
Malin Corporation	EUR 1.1M	400K	2024-12
Moderna	USD 308M	40M	2025-12
Organon & Co	USD 399M	54M	2025-09
Ovoca Bio	EUR 632K	2.33M	2025-06
Revvity	USD 251.73M	9.82M	2025-12
Tectonic Therapeutic	USD 3.44M	1.52M	2025-12
Viatris	USD 1.03B	144.1M	2025-12
Xeris Pharmaceuticals	USD 42.64M	3.82M	2025-12